Document Detail


Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
MedLine Citation:
PMID:  21245103     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Epidermal growth factor receptor (EGFR) imaging in brain tumors is essential to visualize overexpression of EGFRvIII variants as a signature of highly aggressive gliomas and to identify patients that would benefit from anti-EGFR therapy. Seeking imaging improvements, we tested a novel pretargeting approach that relies on initial administration of enzyme-linked anti-EGFR monoclonal antibodies (mAb; EMD72000) followed by administration of a low-molecular-weight paramagnetic molecule (diTyr-GdDTPA) retained at the site of EGFR mAb accumulation. We hypothesized that diTyr-GdDTPA would become enzyme activated and retained on cells due to binding to tissue proteins. In support of this hypothesis, mAb-enzyme conjugates reacted with both membrane-isolated wild-type (wt) EGFR and EGFRvIII, but they bound primarily to EGFRvIII-expressing cells and not to EGFRwt-expressing cells. In vivo analysis of magnetic resonance (MR) tumor signal revealed differences in MR signal decay following diTyr-GdDTPA substrate administration. These differences were significant in that they suggested differences in substrate elimination from the tissue which relied on the specificity of the initial mAb binding: a biexponential signal decay was observed in tumors only upon preinjection with EGFR-targeted conjugates. Endpoint MRI in this setting revealed detailed images of tumors which correlated with immunohistochemical detection of EGFR expression. Together, our findings suggest an improved method to identify EGFRvIII-expressing gliomas in vivo that are best suited for treatment with therapeutic EGFR antibodies.
Authors:
Mohammed S Shazeeb; Christopher H Sotak; Michael DeLeo; Alexei Bogdanov
Related Documents :
20018323 - Magnetic resonance urethrography to assess obliterative posterior urethral stricture: c...
18718233 - Evaluation of the upper urinary tract using transureteric ultrasound--a review of the t...
3680683 - Pseudomembranous colitis: ct evaluation.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2011-01-18
Journal Detail:
Title:  Cancer research     Volume:  71     ISSN:  1538-7445     ISO Abbreviation:  Cancer Res.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-16     Completed Date:  2011-07-25     Revised Date:  2012-03-19    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2230-9     Citation Subset:  IM    
Copyright Information:
©2011 AACR.
Affiliation:
Department of Biomedical Engineering, Worcester Polytechnic Institute, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Monoclonal / chemistry,  metabolism
Antibodies, Monoclonal, Humanized
Brain Neoplasms / genetics,  metabolism*,  pathology
Cell Line, Tumor
Gadolinium DTPA / chemistry,  metabolism
Glioma / genetics,  metabolism*,  pathology
Horseradish Peroxidase / chemistry,  metabolism
Humans
Image Enhancement
Magnetic Resonance Imaging / methods*
Mutation
Neoplasm Transplantation
Rats
Rats, Nude
Receptor, Epidermal Growth Factor / chemistry,  genetics,  metabolism*
Reproducibility of Results
Signal Processing, Computer-Assisted
Transplantation, Heterologous
Grant Support
ID/Acronym/Agency:
5R01EB000858/EB/NIBIB NIH HHS; R01 AG034901-02/AG/NIA NIH HHS; R01 EB000858-09/EB/NIBIB NIH HHS; R21 NS061132-02S1/NS/NINDS NIH HHS; R33 CA134385-03/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; 0/epidermal growth factor receptor VIII; 0/matuzumab; 80529-93-7/Gadolinium DTPA; EC 1.11.1.-/Horseradish Peroxidase; EC 2.7.10.1/Receptor, Epidermal Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
Next Document:  Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass...